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A previously healthy 14-year-old girl presented to the 
emergency department with high fever, cough, shortness of 
breath and right lobar pneumonia on chest radiograph. She 
had extensive purpura with hemorrhagic bullae on her left 
leg. The patient was very ill-appearing with hypotension, 
tachycardia, tachypnea, and oliguria. There was no other 
bleeding. Hemogram showed leukocytosis (13000/cmm) 
with 35% bands, platelets 76,000/ml and sedimentation rate 
of 98 mm. The prothrombin time and partial thromboplastin 
time were prolonged and the fibrin degradation products were 
grossly elevated. Blood culture grew group-A streptococci. A 
diagnosis of purpura fulminans from septic shock was made. 
She was resuscitated and given parenteral antibiotics and 
platelets. The patient recovered within two weeks and later 
had skin grafting.
Purpura fulminans is an infrequent, often fatal, acute 
cutaneous reaction resulting from infective or non-infective 
conditions.1 When it arises during sepsis, in-hospital mortality 
is 42%.2 Antecedent infections are most commonly group-A 
streptococcus, staphylococcus, peumococcus, vibrio, and 
meningococcus, and less commonly varicella.3 Neonates with 
protein C and protein S deficiencies are at higher risk for 
purpura fulminans. Patients with systemic lupus erythematosis 
may have antiphospholipid antibody syndrome.1 The disease 
may occur without preceding illness.1 
Purpura fulminans from sepsis requires surgical 
debridement, skin grafting and even amputation.4 Normal 
saline resuscitation restores volume and promotes urine 
output >0.5ml/kg/hour.5 Although there is no proven benefit, 
treatment of severe disseminated intravascular coagulation 
with purpura fulminans with heparin may be warranted.5,6 
Most clinicians prefer to provide platelet replacement if 
platelet counts drop below 20,000/mL.5,6 Administration of 
protein C concentrate early in the course of the disease may 
reduce both morbidity and mortality.3 There is some evidence 
that recombinant tissue plasminogen activator infusion may 
result in improved organ perfusion and cardiac performance.7
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Figure.  Extensive areas of purpura, ecchymosis and skin 
necrosis with hemorrhagic blebs and disrupted bullae, involving 
the left lower extremity. 